Early Alzheimer’s Egg-Shell Protein Therapy Shows Promise in Small Human Study 7 months ago JohnIn Clinical TrialsStartups
Ultragenyx Gene Therapy Rejected by FDA Even as Takeda Scores Big in Narcolepsy Trial 9 months ago JohnIn Clinical TrialsFDA Approvals
FDA Rejects UltraGeneX’s Gene Therapy Application, Pivotal Phase III Reads Out for Takeda Narcolepsy Drug 9 months ago JohnIn Breaking NewsFDA Approvals
CSL Enters Major Partnership with VarmX to Advance Bleeding Management Drug 9 months ago JohnIn Biopharma HighlightsPartnerships
New Phase 1/2 Study Shows Promise for Oral Alzheimer’s Drug in Early Alzheimer’s Disease 9 months ago JohnIn Breaking NewsBreakthroughsInnovationTop Stories
Setrusumab Trial Update Disappoints Investors Despite Continued Clinical Progress 9 months ago JohnIn InvestmentsVenture Capital
New Regulatory Shift: NIH Requires Alternatives to Animal-Only Studies in Funded Research 9 months ago JohnIn Breaking NewsTop Stories
Strong Real-World Data Strengthens Case for Long-Acting HIV Injectables 9 months ago JohnIn Biopharma Highlights
APG777 Shows Strong Skin Clearance in Phase 2 Trial for Moderate-to-Severe Atopic Dermatitis 9 months ago JohnIn Clinical TrialsInnovationTop Stories
Bezuclastinib Delivers Strong Symptom Relief in Systemic Mastocytosis Trial 9 months ago JohnIn Clinical Trials
Rusfertide Meets Key Endpoints in Phase 3 Trial for Polycythemia Vera 9 months ago JohnIn Clinical TrialsResearch Updates
FDA and EMA Approve Phase III Trial of Masitinib Plus Docetaxel for Advanced Prostate Cancer 9 months ago JohnIn FDA ApprovalsResearch UpdatesTop Stories
FDA Gives Accelerated Approval to Lynozyfic for Hard-to-Treat Multiple Myeloma 9 months ago JohnIn FDA ApprovalsResearch UpdatesTop Stories
